FDA official logo
GSRS logo
PFDA official logo

GARADACIMAB

  • UNII: 32W6AJL0DY
  • Preferred Substance Name: GARADACIMAB

  • 2162134-62-3
  • CSL-312
  • CSL312 (ANTI-FXIIA MONOCLONAL ANTIBODY)
  • GARADACIMAB [INN]
  • GARADACIMAB [WHO-DD]
  • IMMUNOGLOBULIN G4, ANTI-(HUMAN BLOOD-COAGULATION FACTOR XIIA) (HUMAN MONOCLONAL CSL312 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CSL312 .LAMBDA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS F12 (COAGULATION FACTOR XII, HAGEMAN FACTOR) ACTIVATED (F12A, FXIIA)), MONOCLONAL ANTIBODY

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.